Panacea Biotec Ltd.

•

panaceabiotec.comBSE: 531349NSE: PANACEABIO

Market Cap₹ 2,438 Cr.

Current Price

High / Low₹ 647 / 292

Stock P/E—

Book Value₹ 137

Price to Book3.23

Dividend Yield0.00 %

ROCE-0.5 %

ROE-1.0 %

Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Vaccines: 55.4% • Formulations: 44.6%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 10.15x)
Company generates healthy free cash flow
Institutional investors have been accumulating - FII+DII up 2.3pp

CONS

Company is loss-making at the operating / net level
Recent results are weak - TTM profit is down 326.4% versus prior year
Operating cash flow has been negative in recent years
Company has a low return on equity of -1.7% over last 3 years
Receivables are growing faster than sales - a possible quality concern
Company has a low return on capital employed of 0.7%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	PANACEABIO	398.05	0.00	2438.09	0.00	2.20	-44.44	199.57	19.72	-0.47	2.84

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	129	143	150	136	116	147	163	133	167	141	165	167	200
	140	147	151	142	130	140	156	159	168	159	153	164	203
Operating Profit	-10	-4	-0	-6	-14	7	8	-27	-1	-18	12	3	-3
OPM %	-7.98%	-2.49%	-0.10%	-4.43%	-12.09%	4.75%	4.87%	-20.28%	-0.71%	-12.61%	7.11%	1.54%	-1.71%
	34	6	8	14	7	7	6	36	17	9	5	5	2
Interest	1	1	1	1	1	1	1	1	1	2	2	1	1
Depreciation	9	9	9	9	9	9	9	8	8	8	8	8	8
Profit before Tax	13	-8	-2	-2	-17	5	4	-0	7	-19	6	-1	4
Tax %	15.73%	-6.56%	-33.33%	6.13%	6.86%	1.05%	-1.37%	-4875.00%	39.63%	26.92%	40.06%	20.00%	38.38%
Net Profit	0	0	0	0	-16	5	4	-2	4	-14	4	-1	2
	1.79	-1.35	-0.37	-0.23	-2.59	0.77	0.74	-0.31	0.66	-2.27	0.65	0.08	0.38

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	653	544	593	457	544	625	661	460	559	559	673
	541	497	508	590	519	548	674	558	579	585	680
Operating Profit	112	47	85	-133	25	77	-13	-98	-20	-26	-7
OPM %	17.11%	8.66%	14.26%	-29.15%	4.68%	12.26%	-2.00%	-21.30%	-3.59%	-4.63%	-1.02%
	70	54	8	339	15	10	1,687	154	62	57	21
Interest	127	101	101	105	174	185	181	4	4	4	6
Depreciation	73	68	59	55	44	46	44	39	37	35	33
Profit before Tax	-19	-67	-66	46	-178	-144	1,449	13	1	-8	-10
Tax %	-10.14%	16.28%	-14.86%	18.57%	-9.54%	-1.36%	25.60%	363.53%	201.90%	-9.70%	13.90%
Net Profit	-21	-56	-76	38	-195	-146	1,078	-34	-2	-9	-9
EPS	0.00	0.00	0.00	0.00	0.00	-24.11	176.05	-5.43	-0.19	-1.37	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: -2%
5 Years:: 1%
3 Years:: -5%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: 14%
5 Years:: 6%
3 Years:: 45%
1 Year:: -7%

RETURN ON EQUITY

10 Years:: 21%
5 Years:: 66%
3 Years:: -2%
Last Year:: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	6	6	6	6	6	6	6	6	6	6
Minority Interest	1	11	-3	-3	-3	-3	-3	-3	-4	-4
	426	350	303	344	161	-235	871	837	836	829
	1,107	1,000	945	650	829	1,014	80	52	43	34
Trade Payables	188	249	277	270	199	247	235	177	146	226
	296	159	64	88	367	148	547	373	385	211
Total Liabilities	2,025	1,774	1,592	1,356	1,559	1,177	1,735	1,443	1,412	1,301
	1,071	1,001	949	806	657	609	622	600	569	551
Capital Work in Progress	105	9	8	8	10	21	5	28	75	94
	9	7	7	5	6	0	5	13	40	3
	305	316	334	81	148	174	213	202	178	214
	0	0	0	0	0	0	0	0	57	73
Cash & Bank	23	14	23	23	90	136	583	226	122	107
	511	427	271	432	649	237	307	373	371	260
Total Assets	2,025	1,774	1,592	1,356	1,559	1,177	1,735	1,443	1,412	1,301

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	72	126	122	103	-22	108	295	-420	3	-27
Cash from Investing	16	-26	55	-5	-35	-48	1,283	430	7	65
Cash from Financing	-117	-107	-164	-101	91	-47	-1,176	-18	-3	-3
	-10	-2	9	-2	26	12	-2	-10	7	35

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	73.46	72.87	72.49	72.48	72.48	72.48	72.48	72.48	72.48
	0.26	0.37	0.38	1.16	0.79	1.06	1.36	1.60	2.31
	1.07	1.16	1.16	1.49	1.52	1.80	1.85	1.96	2.25
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	25.20	25.60	25.97	24.87	25.22	24.66	24.31	23.96	22.96

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08

Copy of Newspaper Publication

2026-09-08 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication - Post dispatch of AGM Notice

2026-09-07

General Updates

2026-09-07 - Panacea Biotec Limited has informed the Exchange about General Updates - Book closure for the purpose of AGM

2026-09-07

General Updates

2026-09-07 - Panacea Biotec Limited has informed the Exchange about General Updates - Confirmation on letter being sent to the concerned shareholders providing the weblink for accessing the Annual Report for financial year 2025-26 and the Notice of the ensuing AGM, to be held on September 29, 2026, through Video Conferencing / Other Audio-Visual Means.

2026-09-07

Shareholders meeting

2026-09-07 - Panacea Biotec Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026

2026-09-07

Updates

2026-09-07 - Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during August 2026'.

2026-08-18

Copy of Newspaper Publication

2026-08-18 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-14

Copy of Newspaper Publication

2026-08-14 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-13

Outcome of Board Meeting

2026-08-13 - Panacea Biotec Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-12

Copy of Newspaper Publication

2026-08-12 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication

News

Recent coverage and analyst commentary for PANACEABIO

Loading news…

🤖

AI Stock Analyst

Panacea Biotec Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

PANACEABIO

398.05

0.00

2438.09

0.00

2.20

-44.44

199.57

19.72

-0.47

2.84

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

129

143

150

136

116

147

163

133

167

141

165

167

200

140

147

151

142

130

140

156

159

168

159

153

164

203

Operating Profit

-10

-4

-0

-6

-14

-27

-1

-18

-3

OPM %

-7.98%

-2.49%

-0.10%

-4.43%

-12.09%

4.75%

4.87%

-20.28%

-0.71%

-12.61%

7.11%

1.54%

-1.71%

Interest

Depreciation

Profit before Tax

-8

-2

-17

-0

-19

-1

Tax %

15.73%

-6.56%

-33.33%

6.13%

6.86%

1.05%

-1.37%

-4875.00%

39.63%

26.92%

40.06%

20.00%

38.38%

Net Profit

-16

-2

-14

-1

1.79

-1.35

-0.37

-0.23

-2.59

0.77

0.74

-0.31

0.66

-2.27

0.65

0.08

0.38

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

653

544

593

457

544

625

661

460

559

673

541

497

508

590

519

548

674

558

579

585

680

Operating Profit

112

-133

-13

-98

-20

-26

-7

OPM %

17.11%

8.66%

14.26%

-29.15%

4.68%

12.26%

-2.00%

-21.30%

-3.59%

-4.63%

-1.02%

339

1,687

154

Interest

127

101

105

174

185

181

Depreciation

Profit before Tax

-19

-67

-66

-178

-144

1,449

-8

-10

Tax %

-10.14%

16.28%

-14.86%

18.57%

-9.54%

-1.36%

25.60%

363.53%

201.90%

-9.70%

13.90%

Net Profit

-21

-56

-76

-195

-146

1,078

-34

-2

-9

EPS

0.00

-24.11

176.05

-5.43

-0.19

-1.37

—

Dividend Payout %

0.00%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Minority Interest

-3

-4

426

350

303

344

161

-235

871

837

836

829

1,107

1,000

945

650

829

1,014

Trade Payables

188

249

277

270

199

247

235

177

146

226

296

159

367

148

547

373

385

211

Total Liabilities

2,025

1,774

1,592

1,356

1,559

1,177

1,735

1,443

1,412

1,301

1,071

1,001

949

806

657

609

622

600

569

551

Capital Work in Progress

105

305

316

334

148

174

213

202

178

214

Cash & Bank

136

583

226

122

107

511

427

271

432

649

237

307

373

371

260

Total Assets

2,025

1,774

1,592

1,356

1,559

1,177

1,735

1,443

1,412

1,301

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

126

122

103

-22

108

295

-420

-27

Cash from Investing

-26

-5

-35

-48

1,283

430

Cash from Financing

-117

-107

-164

-101

-47

-1,176

-18

-3

-10

-2

-10

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

73.46

72.87

72.49

72.48

0.26

0.37

0.38

1.16

0.79

1.06

1.36

1.60

2.31

1.07

1.16

1.49

1.52

1.80

1.85

1.96

2.25

Government

0.00

25.20

25.60

25.97

24.87

25.22

24.66

24.31

23.96

22.96

Panacea Biotec Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Panacea Biotec Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI